HC Wainwright Reiterates “Buy” Rating for Vir Biotechnology (NASDAQ:VIR)
Vir Biotechnology (NASDAQ:VIR – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research note issued to investors on Friday,Benzinga reports. They presently have a $110.00 price target on the stock. HC Wainwright also issued estimates for Vir Biotechnology’s Q1 2026 earnings at ($0.80) EPS, Q2 2026 […]
Vir Biotechnology (NASDAQ:VIR – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research note issued to investors on Friday,Benzinga reports. They presently have a $110.00 price target on the stock. HC Wainwright also issued estimates for Vir Biotechnology’s Q1 2026 earnings at ($0.80) EPS, Q2 2026 […]
